What has NICE said?
Ranibizumab is recommended as a possible treatment for sight problems caused by choroidal neovascularisation in people who also have pathological myopia.
Ranibizumab is recommended as a possible treatment for sight problems caused by choroidal neovascularisation in people who also have pathological myopia.